BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Neurobiological Technologies, Inc. 

2000 Powell Street
Suite 800
Emeryville  California  94608  U.S.A.
Phone: 510-595-6000 Fax: 510-595-6006


SEARCH JOBS



Segment
Drug Discovery





 Company News
Neurobiological Technologies, Inc. (NTII) Announces Dividend of $0.05 Per Share 12/17/2012 9:39:08 AM    More...
Neurobiological Technologies, Inc. (NTII) Announces Extraordinary Dividend of $0.18 per Share Company also Announces Timing and Plans to Voluntarily Delist from the Nasdaq Capital Market and Initiate Dissolution Process 11/23/2009 9:52:26 AM    More...
Neurobiological Technologies, Inc. (NTII) Announces Intent to File Form 25 to Delist Common Stock From the The Nasdaq Stock Market -- New York Capital Market 10/20/2009 11:24:20 AM    More...
Neurobiological Technologies, Inc. (NTII) Board Approves Liquidation Plan 9/1/2009 7:56:58 AM    More...
Neurobiological Technologies, Inc. (NTII) Announces Termination of its License and Cooperation Agreement with Merz Pharmaceuticals, LLC and Children's Medical Center 8/12/2009 6:43:47 AM    More...
Celtic Pharma Announces Results of XERECEPT(R) Phase 3 Clinical Program 6/1/2009 11:30:58 AM    More...
Neurobiological Technologies, Inc. (NTII) Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine 5/4/2009 7:54:45 AM    More...
Neurobiological Technologies, Inc. (NTII) Announces Appointment of William A. Fletcher as Acting CEO 2/4/2009 7:29:12 AM    More...
Neurobiological Technologies, Inc. (NTII) Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine 2/3/2009 8:26:16 AM    More...
Neurobiological Technologies, Inc. (NTII) Ends Stroke Drug Development; Cuts Jobs 1/13/2009 6:32:44 AM    More...
12345678910...

//-->